LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 102 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,973 | -55.1% | 10,000 | -33.3% | 0.00% | -66.7% |
Q1 2024 | $22,200 | +103.7% | 15,000 | +50.0% | 0.01% | +100.0% |
Q4 2023 | $10,900 | -7.6% | 10,000 | 0.0% | 0.00% | -25.0% |
Q3 2023 | $11,800 | -16.3% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $14,100 | -6.0% | 10,000 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $15,000 | +28.2% | 10,000 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $11,700 | -26.9% | 10,000 | 0.0% | 0.00% | -42.9% |
Q2 2022 | $16,000 | +6.7% | 10,000 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $15,000 | -40.0% | 10,000 | 0.0% | 0.01% | -33.3% |
Q4 2021 | $25,000 | 0.0% | 10,000 | 0.0% | 0.01% | -10.0% |
Q3 2021 | $25,000 | -13.8% | 10,000 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $29,000 | +20.8% | 10,000 | 0.0% | 0.01% | +20.0% |
Q1 2021 | $24,000 | +33.3% | 10,000 | 0.0% | 0.01% | +25.0% |
Q4 2020 | $18,000 | +100.0% | 10,000 | 0.0% | 0.01% | +60.0% |
Q3 2020 | $9,000 | 0.0% | 10,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $9,000 | +12.5% | 10,000 | 0.0% | 0.01% | -28.6% |
Q1 2020 | $8,000 | -11.1% | 10,000 | 0.0% | 0.01% | -12.5% |
Q4 2019 | $9,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $52,403,228 | 3.69% |
Raffles Associates | 1,536,946 | $2,305,419 | 3.14% |
Defender Capital, LLC. | 5,136,085 | $7,704,128 | 2.69% |
Prescott General Partners LLC | 1,851,851 | $2,777,777 | 0.22% |
DAFNA Capital Management LLC | 140,000 | $210,000 | 0.06% |
Beirne Wealth Consulting Services, LLC | 45,000 | $67,500 | 0.05% |
CTC Capital Management, LLC | 14,100 | $21,150 | 0.04% |
Diametric Capital, LP | 50,875 | $76,313 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $1,172,649 | 0.03% |
One68 Global Capital, LLC | 13,377 | $20,066 | 0.03% |